Table of Contents
LOTRONEX® FDA Gastrointestinal Drugs Advisory Committee
LOTRONEX
FDA Request for Advisory Meeting
Risk Management for Lotronex
Fundamental Questions
Has the Safety Profile Changed?
Risk Management Program
Summary
Glaxo Wellcome Presentation: AGENDA
|
Author: stj11454
|